Company intelligence / Profile preview

mySymptoms

United Kingdomrightdecisions.scot.nhs.uk ↗

Ownership: Private
Development stage: Commercial

Overview

mySymptoms is a commercially available mobile application used by over 700,000 people to track diet and symptoms. It helps users identify patterns between dietary habits and symptoms such as IBS, IBD, migraines, eczema and more. The app offers advanced analytics to uncover correlations between foods and symptoms. It is featured in ‘The Best Gut Health Apps’ by Healthline.

Therapeutic areas: GastroenterologyDermatologyImmunologyNeurology
Modalities: Non-pharmacological therapyDevice (mobile application)
Industry: Digital Health Medical Devices

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed; some clinical collaborations possible via clinician web portal

Beyond the preview

Go deeper on mySymptoms.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on mySymptoms.

Explore the full profile